Search

everythinglearnresearchcommunity

for

Search:↓

A mutation in the vitamin D receptor causes severe resistance to vitamin D, affecting bone health but not hair growth.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

α-MSH increases melanin production in moulting hair follicles, while AVT inhibits it.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Side effects of drugs can lead to the discovery of new treatments.

Acute stress increases Y1 receptor gene expression in certain brain areas, but repeated stress does not.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Neurosteroids in the brain can increase or decrease seizure risk in mice.

Quercitrin may help treat Alzheimer's by boosting brain cell signaling without causing tumors.

Sodium metabisulfite increases sodium channel activity, leading to higher cell excitability and potential damage.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Neurosteroids may help metyrapone reduce cocaine addiction.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.